UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11206) 11206
Magazine Article (9) 9
Book Chapter (8) 8
Conference Proceeding (7) 7
Publication (7) 7
Book Review (2) 2
Dissertation (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9952) 9952
science & technology (7886) 7886
life sciences & biomedicine (7678) 7678
antimetabolites, antineoplastic - administration & dosage (6425) 6425
female (6158) 6158
male (6007) 6007
middle aged (4636) 4636
oncology (4443) 4443
aged (4271) 4271
antimetabolites, antineoplastic - therapeutic use (4071) 4071
adult (3320) 3320
antimetabolites, antineoplastic - adverse effects (2924) 2924
deoxycytidine - analogs & derivatives (2829) 2829
fluorouracil - administration & dosage (2747) 2747
antineoplastic combined chemotherapy protocols - therapeutic use (2456) 2456
treatment outcome (2437) 2437
animals (2160) 2160
chemotherapy (2029) 2029
cancer (1843) 1843
deoxycytidine - administration & dosage (1772) 1772
pharmacology & pharmacy (1675) 1675
antimetabolites, antineoplastic - pharmacology (1464) 1464
drug administration schedule (1435) 1435
aged, 80 and over (1368) 1368
fluorouracil - therapeutic use (1337) 1337
deoxycytidine - therapeutic use (1211) 1211
mice (1118) 1118
combined modality therapy (1114) 1114
antimetabolites, antineoplastic - pharmacokinetics (1101) 1101
gemcitabine (1081) 1081
methotrexate - administration & dosage (1061) 1061
fluorouracil - adverse effects (1002) 1002
medicine & public health (980) 980
care and treatment (972) 972
5-fluorouracil (946) 946
drug combinations (925) 925
capecitabine (908) 908
dose-response relationship, drug (907) 907
deoxycytidine - adverse effects (905) 905
antineoplastic combined chemotherapy protocols - adverse effects (902) 902
survival analysis (882) 882
hematology (878) 878
adenocarcinoma - drug therapy (875) 875
antineoplastic agents - administration & dosage (873) 873
retrospective studies (873) 873
survival rate (864) 864
colorectal neoplasms - drug therapy (844) 844
disease-free survival (843) 843
pancreatic neoplasms - drug therapy (840) 840
time factors (812) 812
neoplasm staging (805) 805
administration, oral (801) 801
cisplatin - administration & dosage (794) 794
methotrexate (788) 788
chemotherapy, adjuvant (763) 763
prognosis (758) 758
cell line, tumor (752) 752
fluorouracil - analogs & derivatives (749) 749
infusions, intravenous (746) 746
antineoplastic combined chemotherapy protocols - administration & dosage (738) 738
research (732) 732
adolescent (711) 711
tegafur - administration & dosage (711) 711
surgery (670) 670
abridged index medicus (667) 667
analysis (653) 653
fluorouracil (643) 643
follow-up studies (641) 641
breast neoplasms - drug therapy (630) 630
leucovorin - administration & dosage (621) 621
rats (604) 604
colorectal cancer (603) 603
stomach neoplasms - drug therapy (594) 594
antineoplastic agents (587) 587
pancreatic cancer (586) 586
lung neoplasms - drug therapy (585) 585
drug therapy (569) 569
child (568) 568
neoplasms - drug therapy (555) 555
remission induction (553) 553
antineoplastic agents, phytogenic - administration & dosage (542) 542
liver neoplasms - secondary (532) 532
oxonic acid - administration & dosage (530) 530
cytarabine - administration & dosage (528) 528
fluorouracil - pharmacology (526) 526
health aspects (526) 526
antimitotic agents (518) 518
methotrexate - adverse effects (511) 511
dosage and administration (497) 497
liver neoplasms - drug therapy (496) 496
antineoplastic agents - therapeutic use (490) 490
prospective studies (490) 490
pancreatic neoplasms - pathology (476) 476
colorectal neoplasms - pathology (474) 474
pharmacology/toxicology (465) 465
risk factors (457) 457
tegafur - therapeutic use (457) 457
methotrexate - therapeutic use (438) 438
toxicity (437) 437
fluorouracil - pharmacokinetics (432) 432
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10151) 10151
Japanese (930) 930
French (169) 169
German (141) 141
Chinese (101) 101
Russian (75) 75
Italian (60) 60
Spanish (50) 50
Portuguese (17) 17
Polish (15) 15
Hungarian (11) 11
Norwegian (10) 10
Danish (9) 9
Lithuanian (9) 9
Ukrainian (5) 5
Bulgarian (4) 4
Dutch (4) 4
Hebrew (4) 4
Czech (3) 3
Korean (2) 2
Swedish (2) 2
Finnish (1) 1
Kurdish (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 08/2013, Volume 31, Issue 23, pp. 2895 - 2902
Journal Article
Annals of oncology, ISSN 1569-8041, 11/2012, Volume 23, Issue 11, pp. 2799 - 2805
Sorafenib is an oral anticancer agent targeting Ras-dependent signaling and angiogenic pathways. A phase I trial demonstrated that the combination of... 
phase III randomized trial | gemcitabine | sorafenib | advanced pancreatic cancer | Advanced pancreatic cancer | Gemcitabine | Sorafenib | Phase III randomized trial | Life Sciences & Biomedicine | Oncology | Science & Technology | Niacinamide - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Placebos | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Deoxycytidine - administration & dosage | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Niacinamide - administration & dosage | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Ribonucleotide Reductases - antagonists & inhibitors | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 05/2016, Volume 229, pp. 154 - 162
...) that inarguably offers superior therapeutic efficacies compared to free drug administrations. Delivery of synergistic ratios of this drug pair led to greater than 90... 
Synergistic | Nanoparticles | Chemotherapy | Drug combinations | Liposomes | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Neoplasms - metabolism | Doxorubicin - therapeutic use | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Tryptophan - chemistry | Polyethylene Glycols - chemistry | Doxorubicin - chemistry | Antimetabolites, Antineoplastic - administration & dosage | Fluorouracil - therapeutic use | Fluorouracil - administration & dosage | Antibiotics, Antineoplastic - chemistry | Female | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Cell Line | Antimetabolites, Antineoplastic - chemistry | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Antimetabolites, Antineoplastic - therapeutic use | Animals | Antibiotics, Antineoplastic - therapeutic use | Tumor Burden - drug effects | Fluorouracil - chemistry | Cell Line, Tumor | Mice, Inbred BALB C | Fluorouracil - pharmacokinetics | Neoplasms - pathology | Drug Combinations | Drugs | Anthracyclines | Drug delivery systems | Sulfates | Vehicles | Cancer | School facilities | Biomedical engineering | Education parks | Index Medicus | synergistic | nanoparticles | liposomes | chemotherapy
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 01/2013, Volume 31, Issue 1, pp. 23 - 29
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 02/2000, Volume 18, Issue 4, pp. 854 - 854
Purpose: To evaluate the results of etoposide, cisplatin/etoposide, methotrexate, and actinomycin D (EP/EMA) chemotherapy in patients with gestational... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Antineoplastic Agents - administration & dosage | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Agents - adverse effects | Dactinomycin - adverse effects | Chorionic Gonadotropin - blood | Adult | Female | Antineoplastic Agents, Phytogenic - adverse effects | Etoposide - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Dactinomycin - administration & dosage | Remission Induction | Antibiotics, Antineoplastic - administration & dosage | Pregnancy | Methotrexate - adverse effects | Uterine Neoplasms - surgery | Trophoblastic Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Trophoblastic Neoplasms - surgery | Trophoblastic Neoplasms - secondary | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Placenta - pathology | Uterine Neoplasms - drug therapy | Cisplatin - adverse effects | Methotrexate - administration & dosage | Antineoplastic Agents, Alkylating - adverse effects | Cohort Studies | Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2013, Volume 31, Issue 23, pp. 2849 - 2853
Journal Article
Journal of the Pancreas, ISSN 1590-8577, 09/2012, Volume 13, Issue 5, pp. 497 - 501
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 7/2011, Volume 68, Issue 1, pp. 147 - 156
... as part of a multidrug regimen. The effect of clinical and surgical factors on drug distribution after single intraperitoneal bolus administration... 
Chemotherapy pharmacokinetics | Medicine & Public Health | Cytoreductive surgery | Intraperitoneal chemotherapy | Hyperthermic intraperitoneal chemotherapy (HIPEC) | Colorectal cancer | Oncology | Cancer Research | Mitomycin C | Appendix cancer | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Colorectal Neoplasms - surgery | Antibiotics, Antineoplastic - pharmacology | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Antibiotics, Antineoplastic - blood | Antimetabolites, Antineoplastic - administration & dosage | Antineoplastic Agents - metabolism | Young Adult | Colorectal Neoplasms - therapy | Peritoneal Neoplasms - drug therapy | Fluorouracil - administration & dosage | Retroperitoneal Neoplasms - drug therapy | Colorectal Neoplasms - drug therapy | Hyperthermia, Induced | Adult | Antimetabolites, Antineoplastic - pharmacology | Appendiceal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Antibiotics, Antineoplastic - pharmacokinetics | Retroperitoneal Neoplasms - surgery | Antimetabolites, Antineoplastic - metabolism | Carcinoma - drug therapy | Fluorouracil - metabolism | Mitomycin - blood | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Injections, Intraperitoneal | Appendiceal Neoplasms - surgery | Combined Modality Therapy | Mitomycin - pharmacology | Antibiotics, Antineoplastic - administration & dosage | Carcinoma - therapy | Aged | Fluorouracil - pharmacology | Mitomycin - pharmacokinetics | Mitomycin - administration & dosage | Peritoneal Neoplasms - therapy | Chemotherapy | Mitomycin | Cancer | Index Medicus
Journal Article